Smith & Nephew plc vs Symbotic Inc — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Symbotic Inc trades at $43.33 (market cap $5.19B). The key difference: Smith & Nephew plc is far larger — about 2.4× Symbotic Inc's market cap, and Smith & Nephew plc pays a 2.57% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| SNN | SYM | |
|---|---|---|
Market Cap | $12.64B | $5.19B |
Sector | Health | Technology |
52-Week High | $38.70 | $87.30 |
52-Week Low | $28.73 | $38.57 |
Enterprise Value | $15.41B | $3.18B |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →